Skip to content

Clinical trials

Ovarian Neoplasms trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Country / region: Singapore Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20081
20091
20101
20112
20141
20154
20164
20171
20182
20201
20213
20226
20231
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated10
Completed8
Active, not recruiting6
Recruiting5
Unknown status5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Pfizer3
National University Hospital, Singapore2
ARCAGY/ GINECO GROUP1
Amgen1
Array Biopharma, now a wholly owned subsidiary of Pfizer1
AstraZeneca1
Atavistik Bio, Inc1
Bayer1
BerGenBio ASA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms34
Fallopian Tube Neoplasms8
Endometrial Neoplasms7
Carcinoma, Non-Small-Cell Lung6
Colorectal Neoplasms6
Triple Negative Breast Neoplasms6
Breast Neoplasms5
Carcinoma, Ovarian Epithelial5
Pancreatic Neoplasms5
Neoplasms4

Trials

Showing 26 to 34 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.